Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy
- 1 December 1992
- journal article
- clinical trial
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 25 (4) , 231-241
- https://doi.org/10.1016/0167-8140(92)90242-m
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Astro plenary: Interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: Results from radiation therapy oncology group protocol 8313International Journal of Radiation Oncology*Biology*Physics, 1991
- Hyperfractionated compared with conventional radiotherapy in oropharyngeal carcinoma: an EORTC randomized trialEuropean Journal of Cancer and Clinical Oncology, 1990
- Hyperfractionation for head and neck cancerInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Primary radiotherapy of squamous cell carcinoma of the oropharynx and pharyngolarynx: Tentative multivariate modelling system to predict the radiocurability of neck nodesInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Quality assurance control in the EORTC cooperative group of radiotherapy. 3. Intercomparison in an anatomical phantomRadiotherapy and Oncology, 1987
- Quality assurance control in the EORTC cooperative group ofradiotherapyRadiotherapy and Oncology, 1986
- Regional outcome in oropharyngeal and pharyngolaryngeal cancer treated with high dose per fraction radiotherapy. Analysis of neck disease response in 1646 casesRadiotherapy and Oncology, 1986
- Quality assurance control in the EORTC cooperative group of radiotherapyRadiotherapy and Oncology, 1986
- Experience with twice-a-day fractionation in clinical radiotherapyAmerican Journal of Roentgenology, 1976
- Clinical dose-response curves of human malignant epithelial tumoursThe British Journal of Radiology, 1973